Solara Active Pharma Sciences Ltd (SOLARA) is currently trading at 545.35 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Solara Active Pharma Sciences Limited is a leading manufacturer and exporter of active pharmaceutical ingredients (APIs) with a diverse portfolio across therapeutic segments, including anthelmintic and anti-malarias. The company's recent performance was impacted by short-term operational disruptions due to an unscheduled shutdown of its Mangalore facility, leading to delayed deliveries and a 2% quarterly revenue decline. Despite setbacks, Solara's underlying business fundamentals remain strong, supported by a resilient operating model with 75% revenue from regulated markets, indicating robust market position. Solara has successfully managed regulatory challenges, having cleared multiple FDA audits across its facilities, which underscores its compliance strength and operational resilience. The company is committed to mitigating liquidity pressures with a keen focus on reducing operational costs, optimizing working capital, and achieving healthy gross margins and EBITDA growth.

Over the past 52 weeks, Solara Active Pharma Sciences Ltd has traded between a low of ₹441.10 and a high of ₹734.20. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Solara Active Pharma Sciences Ltd has a market capitalization of approximately 2,012.84. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Solara Active Pharma Sciences Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 314.38 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

You can buy shares of Solara Active Pharma Sciences Ltd (SOLARA) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.

Based on its market capitalization of 2,012.84 Cr, Solara Active Pharma Sciences Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Solara Active Pharma Sciences Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Solara Active Pharma Sciences Ltd is 314.38. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Solara Active Pharma Sciences Ltd currently does not pay dividends. Companies that do not pay dividends often reinvest profits to support business growth or strengthen operations.

Key risks associated with Solara Active Pharma Sciences Ltd include sector-specific challenges in the Pharmaceuticals industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.